Cigna Group, US1255231003

The Cigna Group stock: RBC raises target to $346

Published on 11/20/2026 at 15:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
RBC lifts its price target for The Cigna Group stock to 346 US dollars after stronger healthcare performance supported the latest earnings beat. Pharmacy risks remain.

RBC sharpens its Cigna view

  • RBC Capital kept its Outperform rating while lifting its price target to 346 US dollars.
  • The analyst cited stronger Cigna Healthcare performance and continued momentum in Specialty and Care Services.
  • Pharmacy Benefit Services headwinds and the company's ACA exchange exit remain important considerations for the outlook.
Cigna Group, US1255231003, Illustration mit AI erstellt.

RBC Capital raised its price target for The Cigna Group to 346 US dollars from 337 US dollars on Thursday, November 19, while maintaining an Outperform rating. Markets Insider reported that the analyst action followed stronger-than-expected performance at Cigna Healthcare and continued momentum in Specialty and Care Services.

Healthcare strength supports target

RBC's assessment linked the latest earnings beat to Cigna Healthcare's performance. The analyst also pointed to momentum in Specialty and Care Services, giving the research note a more constructive view of the operating backdrop.

Pharmacy risks remain relevant

Anticipated headwinds at Pharmacy Benefit Services partly offset the positive operating picture. The company has also exited the Affordable Care Act exchange market, a strategic change that affects the basis for future earnings comparisons.

Management raised its full-year guidance and expressed confidence in at least 10 percent adjusted earnings-per-share growth from a 30 US dollar run-rate base adjusted for the ACA exchange exit. RBC's note nevertheless keeps pharmacy trends and the 2027 execution path central to the investment case.

Current quote and investor context

The Cigna Group stock last traded at 253.25 euros on Lang & Schwarz at 15:33 CET on Friday, November 20, 2026.

The Cigna Group at a glance

  • Company: The Cigna Group
  • ISIN: US1255231003
  • Quote: 253.25 euros on Lang & Schwarz, November 20, 2026, 15:33 CET
  • Analyst action: RBC Capital target raised to 346 US dollars from 337 US dollars; Outperform maintained

The US healthcare market remains an important backdrop for the sector. Current market reports provide broader market context.

More news and analyses on The Cigna Group stock

Disclaimer...
en | US1255231003 | CIGNA GROUP | boerse | 70540273 | bgmi